Replies to post #116458 on TON Strategy Company (TONX)

[trader59]

No, that is completely incorrect, there will be no "new price," the only question is what the underwriter will require as a discount to the current market price. The current market price, whatever it is on the day the offering is submitted with pricing to move forward, will be what the stock is offered for, if not (and its higher) nobody will buy it because (drum roll) it is cheaper in the market.

If the stock offering were approved and presented today, it would enter the market at 30 cents a share and, given the volatility of the stock price and the dilutive nature of the offering, the underwriter is very likely to request a 50% discount so they'll be sure to profit from every share they sell. The math is simple, if the stock price held (and it won't with the dilution), it would be 100M shares sold into the float, which is about what the float is.

[jobynimble]

Shares of our Common Stock sold by the Underwriter to the public will initially be offered at the public offering price set forth on the front cover of this prospectus. Any shares of our Common Stock sold by the Underwriter to securities dealers may be sold at a discount from the initial public offering price not to exceed $ ___ per share. If all the shares of our Common Stock are not sold at the public offering price, the Underwriter may change such price and the other selling terms in agreement with the Company.


The above doesn’t happen in an IPO...

[tedpeele]

CUIN2, you wrote <<Underwriter will have the offering “sold” before it opens at its new price on the market. >>

Then you gave quotes from the S1 that I guess you are thinking support what you wrote above.

I have found a S1 for iBIO back in June 2018 that also used Alliance Global. The wording in the underwriter section is similar to that NFUSZ. They priced it at .90 a share, just slightly BELOW MARKET (this was already a NYSE stock). No sign of an valuation independent of the market price in effect.

I don't see that what you have posted says anything significant to support your claim of a price higher than market. Perhaps you can explain further?

I see you just posted a link 'explaining' why this will be an IPO, but you twice ignored my question to you as to why the amended S1 had the words 'initial public offering' changed to 'public offering'? Clearly that didn't just happen by accident, so why did they do that CUIN2 if this is to be an IPO?

To claim this is an IPO against all evidence and to support this with a link that doesn't really support it - while having presumably a fair number of investors taking your word seriously - well, it needs to be treated responsibly, and calls out for more than a meager claim that you think it is possible.



If you want, here is the S1 for iBio, and press release about it:

https://www.otcmarkets.com/filing/html?id=12823728&guid=OynbUn2YNiKcYyh#TV496836_S1A_HTM_A_017
https://www.cnbc.com/2018/06/22/globe-newswire-ibio-inc-prices-16000000-public-offering.html